Bicalutamide is an androgen receptor inhibitor used in the treatment of Stage D2 metastatic prostate cancer. It is commonly administered in combination with a gonadotropin-releasing hormone (GnRH) analogue or through surgical removal of the testicles to manage metastatic prostate cancer (mPC).
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Search Results for " Bicalutamide "
Bicalutamide Related Products
SynZeal is a leading innovator in pharmaceutical reference standards. We supply high-quality Reference Standards of Bicalutamide, pharmacopeial and non-pharmacopeial Bicalutamide impurities, metabolites, stable isotope products, and nitrosamines (N-NO products). Bicalutamide impurities reference standards are useful in pharmaceutical research. They are useful in product development, ANDA and DMF filing, quality control (QC), method validation, and stability studies. It is also useful in the identification of unknown impurities and the assessment of genotoxic potential.